Datamonitor’s report “Market Dynamics 2001: Cancer Adjunct Therapies - A Market Driven By Increasing Usage” provides in-depth analysis of the current cancer adjuncts market and the future potential of the market to 2008. The report includes: * Sales data and analysis for anti-emetic, bisphosphonate, HGF and cancer analgesics at a global and country level * Competitive positioning and insightful analysis of future market standing of the leading companies in the cancer adjuncts market * Analysis of lifecycle management strategies, including data on current reformulations and line extensions * Sales forecasts for the cancer adjuncts market as a whole, individual drug classes and leading drugs
